[Chikungunya, La Réunion and Mayotte, 2005-2006: an epidemic without a story?].
Many triggering factors for onset of emerging infectious diseases are now recognised, such as: globalisation, demographic increase, population movements, international trade, urbanisation, forest destruction, climate changes, loss in biodiversity, and extreme life conditions such as poverty, famine and war. Epidemic burden is often leading to disasters, in terms of human losses, as well as economic, political or social consequences. These outbreaks may jeopardize within a few weeks or months, industry, trade, or tourism. While dengue and its most severe forms (hemorrhagic and shock syndrome) is spreading all over the tropical world, another arbovirosis, chikungunya disease dramatically spread in Indian Ocean islands where 30 to 75% of population were infected in 2005 and 2006, and then extended its progression towards India, Sri Lanka, Indonesia, Malaysia, Maldives islands with more than a million people infected with the East-African strain, replacing the former Asian strain which was known to prevail more than 30 years ago in India. Patients experience sequelae with disability, work loss, and rarely severe outcome recently identified in La Réunion and Mayotte (French overseas territories). No country, no part of the world may consider itself as protected against such events. However, consequences of emerging or re-emerging diseases are more and more unacceptable when they impact the poorest countries of the world. Viruses, bacteria, as well as wild animals, birds, or arthropods are not stopped by borders. It is time now to promote barriers against infectious diseases, including prevention, anticipation, disease surveillance and research. This is not only for humanitarian reasons, but also for contributing to a sustainable development with equity for worldwide population. This report presents comprehensive actions taken in 2006 for tracing the epidemic and mobilise research, as requested to the task force set up by the Prime Minister by March 20, 2006.
Flahault
Antoine
A
Inserm-UPMC, EHESP, Paris, France.
Aumont
Gilles
G
Boisson
Véronique
V
de Lamballerile
Xavier
X
Favier
François
F
Fontenille
Didier
D
Gaüzère
Bernard-Alex
BA
Journeaux
Sophie
S
Lotteau
Vincent
V
Paupy
Christophe
C
Sanquer
Marie-Anne
MA
Setbon
Michel
M
D018354:Alphavirus Infections / Q000453:epidemiology*; D000818:Animals; D002646:Chikungunya virus; D017507:Comoros / Q000453:epidemiology; D004196:Disease Outbreaks; D004199:Disease Vectors; D006801:Humans; D017508:Reunion / Q000453:epidemiology; D014765:Viral Vaccines; D015047:Zoonoses
D014765:Viral Vaccines